The White House makes an agreement with China on trade and tariffs that is essentially having its bluff called on the cornerstone of Trump's economic agenda. In return, the US doesn't get all that much except higher prices and a promise to keep negotiating. Not exactly expert deal-making. 

Then, Trump tries to ram through negotiating prescription drug prices with pharma companies from the Oval Office, despite the idea being shot down during his first term. Will anything be different this time?

Grant makes sense of both things in today's episode

Support the show

Follow along on social media

X: @mimsnewspod
Instagram: @mimsnewspod
TikTok: @mimsnewspod
Substack: mimsnewspod.substack.com
YouTube: youtube.com/@MIMSnewspod
Bluesky: Granthermes.bsky.social

Follow Grant:
X: @GrantHermes
Insta/TikTok: GrantHermesTV

SPONSORS AND ADS:
Our listeners are smart, loyal, and tuned in — and your brand could be too.
Let’s work together. For sponsorships and custom ad spots, reach out to [email protected]